Sublingual Peptide Administration to Pigs Using Mucoadhesive Bilayer Films Achieves Double-Digit Bioavailability
9:30 am - Thursday 3rd December 2026
- Explore the opportunities and challenges of oromucosal administration as an alternative delivery route for peptide therapeutics, overcoming barriers associated with conventional oral and injectable formulations.
- Discover formulation and delivery strategies that enhance peptide absorption across buccal and sublingual while improving bioavailability, patient convenience, and therapeutic performance.
- Presentation of in vivo PK data in pigs from the EU BUCCAL-PEP consortium (2023- 2026).
